Marriage Counselors in Conway, SC Accepting Medicare
5 Marriage Counselors found. Showing 1 - 5
 Mackenzie Darley Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 164 Waccamaw Medical Park Dr, Conway, SC 29526 Phone: 843-347-4888 |
Michelle L. Little Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 164 Waccamaw Medical Park Dr, Conway, SC 29526 Phone: 843-347-5060 |
 Hartmut Fege, D.MIN Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 164 Waccamaw Medical Park Dr, Conway, SC 29526 Phone: 843-347-5060 |
Ms. Helen M Bayne, M.S. Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 235 Singleton Ridge Rd, Conway, SC 29526 Phone: 843-902-4773 Fax: 843-347-9983 |
Mrs. Eden Noel Dorman, LMFT/I CACP Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 2404 Wise Rd, Conway, SC 29526 Phone: 843-365-8884 |
News Archive
Activity levels may distinguish unipolar from bipolar disorder
The measurement of activity levels may help distinguish patients with unipolar depression from those with bipolar disorder when they are in a remitted or mild/moderate depressive state, say researchers.
Study reveals early signs of cardiac impairment in patients with newly diagnosed lupus
Cardiovascular disease is a leading cause of death in patients with lupus, a systemic autoimmune disease. In a new study in Arthritis & Rheumatology—a journal published by Wiley on behalf of the American College of Rheumatology—imaging tests revealed signs of cardiac impairment in patients newly diagnosed with lupus, even before any symptoms of chest discomfort.
Recent developments at Burnham Institute for Medical Research
New antibiotics for methicillin-resistant Staphylococcus aureus (MRSA) and other pesky bacteria. Andrei Osterman and collaborators have used comparisons of bacterial genomes to identify new targets for antibiotics and produced first-generation chemical inhibitors of a class of bacterial enzymes, called NadDs (nicotinate mononucleotide adenylyltransferases).
Bayer's bioequivalence study comparing Adalat XL to Mylan-Nifedipine Extended Release flawed, says Mylan
Mylan today reported that it has identified multiple flaws within a purported bioequivalence study sponsored by Bayer Inc. of Canada. The study compared Bayer's antihypertensive Adalat(R) XL(R) tablets, 60 mg, marketed in Canada, to Mylan's approved generic version, Mylan-Nifedipine Extended Release tablets, 60 mg, marketed in Canada.
› Verified 7 days ago
Counselors
Pharmacists
Clinical Social Workers
Dentists
Occupational Therapists